FR2100726B1 - - Google Patents

Info

Publication number
FR2100726B1
FR2100726B1 FR7120368A FR7120368A FR2100726B1 FR 2100726 B1 FR2100726 B1 FR 2100726B1 FR 7120368 A FR7120368 A FR 7120368A FR 7120368 A FR7120368 A FR 7120368A FR 2100726 B1 FR2100726 B1 FR 2100726B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7120368A
Other languages
French (fr)
Other versions
FR2100726A1 (cg-RX-API-DMAC10.html
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda GmbH
Original Assignee
Byk Gulden Lomberg Chemische Fabrik GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chemische Fabrik GmbH filed Critical Byk Gulden Lomberg Chemische Fabrik GmbH
Publication of FR2100726A1 publication Critical patent/FR2100726A1/fr
Application granted granted Critical
Publication of FR2100726B1 publication Critical patent/FR2100726B1/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7120368A 1970-06-05 1971-06-04 Expired FR2100726B1 (cg-RX-API-DMAC10.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19702027645 DE2027645A1 (de) 1970-06-05 1970-06-05 Piperazinylalkyl chinazolon (4) den vate, Verfahren zu deren Herstellung und sie enthaltende Arzneimittel

Publications (2)

Publication Number Publication Date
FR2100726A1 FR2100726A1 (cg-RX-API-DMAC10.html) 1972-03-24
FR2100726B1 true FR2100726B1 (cg-RX-API-DMAC10.html) 1975-10-10

Family

ID=5773104

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7120368A Expired FR2100726B1 (cg-RX-API-DMAC10.html) 1970-06-05 1971-06-04

Country Status (10)

Country Link
US (1) US3984555A (cg-RX-API-DMAC10.html)
AT (3) AT318615B (cg-RX-API-DMAC10.html)
BE (1) BE768137A (cg-RX-API-DMAC10.html)
CA (1) CA951319A (cg-RX-API-DMAC10.html)
CH (3) CH558374A (cg-RX-API-DMAC10.html)
DE (1) DE2027645A1 (cg-RX-API-DMAC10.html)
FR (1) FR2100726B1 (cg-RX-API-DMAC10.html)
GB (1) GB1331522A (cg-RX-API-DMAC10.html)
LU (1) LU63267A1 (cg-RX-API-DMAC10.html)
NL (1) NL7107695A (cg-RX-API-DMAC10.html)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4287341A (en) * 1979-11-01 1981-09-01 Pfizer Inc. Alkoxy-substituted-6-chloro-quinazoline-2,4-diones
US6723727B1 (en) * 1996-12-20 2004-04-20 Hoechst Aktiengesellschaft Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them
DE69842109D1 (de) * 1997-08-21 2011-03-10 Shiseido Co Ltd Chinazolin-4-on Derivate, deren Herstellung und deren Verwendung als Haarwuchsmittel oder in äusserlich anzuwendenden Hautpflegemitteln
EP1216242A1 (en) 1999-10-01 2002-06-26 Advanced Medicine, Inc. Macrocyclic quinazolinones and their use as local anesthetics
US6667300B2 (en) 2000-04-25 2003-12-23 Icos Corporation Inhibitors of human phosphatidylinositol 3-kinase delta
US6518277B1 (en) * 2000-04-25 2003-02-11 Icos Corporation Inhibitors of human phosphatidylinositol 3-kinase delta
AUPR201600A0 (en) * 2000-12-11 2001-01-11 Fujisawa Pharmaceutical Co., Ltd. Quinazolinone derivative
WO2003020279A2 (en) 2001-09-05 2003-03-13 Minerva Biotechnologies Corporation Compositions and methods of treatment of cancer
US20030119834A1 (en) * 2001-09-05 2003-06-26 Bamdad Cynthia C. Compositions and methods of treatment of cancer
US7060705B2 (en) 2001-11-07 2006-06-13 Merck & Co., Inc. Mitotic kinesin inhibitors
AUPS019702A0 (en) * 2002-01-29 2002-02-21 Fujisawa Pharmaceutical Co., Ltd. Condensed heterocyclic compounds
AU2003262747A1 (en) * 2002-08-21 2004-03-11 Cytokinetics, Inc. Compounds, compositions, and methods
EP1558260A4 (en) * 2002-11-04 2006-10-25 Nps Pharma Inc CHINAZOLINONE COMPOUNDS AS CALCILYTIC
WO2004111014A1 (en) * 2003-06-06 2004-12-23 Vertex Pharmaceuticals Incorporated Pyrimidine derivatives as modulators of atp-binding cassette transporters
WO2005016348A1 (en) * 2003-08-14 2005-02-24 Icos Corporation Method of inhibiting immune responses stimulated by an endogenous factor
US20050054614A1 (en) * 2003-08-14 2005-03-10 Diacovo Thomas G. Methods of inhibiting leukocyte accumulation
WO2005113556A1 (en) 2004-05-13 2005-12-01 Icos Corporation Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
WO2005117889A1 (en) * 2004-05-25 2005-12-15 Icos Corporation Methods for treating and/or preventing aberrant proliferation of hematopoietic
CA2598409A1 (en) * 2005-02-17 2006-08-24 Icos Corporation Phosphoinositide 3-kinase inhibitors for inhibiting leukocyte accumulation
WO2007110868A2 (en) * 2006-03-28 2007-10-04 Atir Holding S.A. Heterocyclic compounds and uses thereof in the treatment of sexual disorders
US9492449B2 (en) 2008-11-13 2016-11-15 Gilead Calistoga Llc Therapies for hematologic malignancies
CA3092449A1 (en) 2008-11-13 2010-05-20 Gilead Calistoga Llc Therapies for hematologic malignancies
WO2010111432A1 (en) 2009-03-24 2010-09-30 Calistoga Pharmaceuticals Inc. Atropisomers of2-purinyl-3-tolyl-quinazolinone derivatives and methods of use
ES2548253T3 (es) * 2009-04-20 2015-10-15 Gilead Calistoga Llc Métodos para el tratamiento de tumores sólidos
CN102647987A (zh) 2009-07-21 2012-08-22 吉里德卡利斯托加公司 使用pi3k抑制剂治疗肝脏障碍
BRPI1003506B1 (pt) 2010-09-24 2019-12-03 Ache Int Bvi Ltd composto alquil-piperazino-fenil-4(3h)quinazolinonas e uso do composto alquil-piperazino-fenil-4(3h)quinazolinonas associado aos receptores serotoninérgicos 5-ht1a e 5-ht2a
US9353067B2 (en) 2011-04-10 2016-05-31 Atir Holding S.A. Heterocyclic compounds and uses thereof in the treatment of sexual disorders
BR112014021935A2 (pt) 2012-03-05 2019-09-24 Gilead Calistoga Llc formas polimórficas de (s)-2(l-(9h-purin-6-ilamino)propil)-5-fluoro-3-fenilquinazolina-4(3h)ona
AU2013288265B2 (en) 2012-07-09 2017-04-06 Lupin Limited Tetrahydroquinazolinone derivatives as PARP inhibitors
US9708327B2 (en) 2013-12-20 2017-07-18 Gilead Calistoga Llc Polymorphic forms of a hydrochloride salt of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one
WO2015095601A1 (en) 2013-12-20 2015-06-25 Gilead Calistoga Llc Process methods for phosphatidylinositol 3-kinase inhibitors
AU2015274696B2 (en) 2014-06-13 2018-09-27 Gilead Sciences, Inc. Phosphatidylinositol 3-kinase inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1249281B (cg-RX-API-DMAC10.html) * 1963-05-18

Also Published As

Publication number Publication date
LU63267A1 (cg-RX-API-DMAC10.html) 1972-08-23
NL7107695A (cg-RX-API-DMAC10.html) 1971-12-07
CH558374A (de) 1975-01-31
CH557829A (de) 1975-01-15
DE2027645A1 (de) 1971-12-09
AT317899B (de) 1974-09-25
CA951319A (en) 1974-07-16
CH569732A5 (cg-RX-API-DMAC10.html) 1975-11-28
FR2100726A1 (cg-RX-API-DMAC10.html) 1972-03-24
GB1331522A (en) 1973-09-26
AT318628B (de) 1974-11-11
BE768137A (fr) 1971-12-06
US3984555A (en) 1976-10-05
AT318615B (de) 1974-11-11

Similar Documents

Publication Publication Date Title
AR204384A1 (cg-RX-API-DMAC10.html)
ATA96471A (cg-RX-API-DMAC10.html)
AU2044470A (cg-RX-API-DMAC10.html)
AU1146470A (cg-RX-API-DMAC10.html)
AU1473870A (cg-RX-API-DMAC10.html)
AU1336970A (cg-RX-API-DMAC10.html)
AU2085370A (cg-RX-API-DMAC10.html)
AU2017870A (cg-RX-API-DMAC10.html)
AU2130570A (cg-RX-API-DMAC10.html)
AU1833270A (cg-RX-API-DMAC10.html)
AU1716970A (cg-RX-API-DMAC10.html)
AU1326870A (cg-RX-API-DMAC10.html)
AU1517670A (cg-RX-API-DMAC10.html)
AU1591370A (cg-RX-API-DMAC10.html)
AU1872870A (cg-RX-API-DMAC10.html)
AU1277070A (cg-RX-API-DMAC10.html)
AU1328670A (cg-RX-API-DMAC10.html)
AU1343870A (cg-RX-API-DMAC10.html)
AU1235770A (cg-RX-API-DMAC10.html)
AU2144270A (cg-RX-API-DMAC10.html)
AU2131570A (cg-RX-API-DMAC10.html)
AU2130770A (cg-RX-API-DMAC10.html)
AU1189670A (cg-RX-API-DMAC10.html)
AU1581370A (cg-RX-API-DMAC10.html)
AU1881070A (cg-RX-API-DMAC10.html)

Legal Events

Date Code Title Description
ST Notification of lapse